Kicking off 2019 with a new merger is Flex Pharma (NASDAQ:FLKS), a Boston, Massachusetts-based biotechnology company. And it’s paying off. FLKS stock is up nearly 40% today, making it a Yahoo Finance trending ticker of the day.
Flex Pharma, the FLKS Stock, and a New MergerOn Friday, January 4th, Flex Pharma (founded in 2014) announced plans to merge with Salarius Pharmaceuticals LLC. The latter is a privately-held clinical-stage oncology company. “After completing a comprehensive and highly competitive selection process,” explains Flex Pharma CEO Dr. William McVicar, “we are confident that the proposed transaction with Salarius ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.